Skip to Main Content

Author Details

Randy Yeh
Department of Radiology Memorial Sloan Kettering Cancer Center
2017
58
16
PMIDPaper TitleJournal TitlePublished Year
36243572The Clinical Utility of Molecular Imaging in COVID-19: An Update.Semin Nucl Med2023
37568284PET/CT and SPECT/CT Imaging of HER2-Positive Breast Cancer.J Clin Med2023
37394411Imaging the Side Effects of CAR T Cell Therapy: A Primer for the Practicing Radiologist.Acad Radiol2023
37345192Novel Targets, Novel Treatments: The Changing Landscape of Non-Small Cell Lung Cancer.Cancers (Basel)2023
37445572Advances in PET/CT Imaging for Breast Cancer.J Clin Med2023
37268735Gradient-based Volumetric PET Parameters on Immediate Pre-ablation FDG-PET Predict Local Tumor Progression in Patients with Colorectal Liver Metastasis Treated by Microwave Ablation.Cardiovasc Intervent Radiol2023
36396458Initial Results of <sup>68</sup>Ga-FAPI-46 PET/MRI to Assess Response to Neoadjuvant Chemotherapy in Breast Cancer.J Nucl Med2023
36803004Emerging and Evolving Concepts in Cancer Immunotherapy Imaging.Radiology2023
36900136More than Just Skin-Deep: A Review of Imaging's Role in Guiding CAR T-Cell Therapy for Advanced Melanoma.Diagnostics (Basel)2023
36762546Durvalumab and PET-Directed Chemoradiation in Locally Advanced Esophageal Adenocarcinoma: A Phase Ib/II Study.Ann Surg2023
34620729<sup>18</sup>F-FDG PET/CT for Posttreatment Surveillance Imaging of Patients with Stage III Merkel Cell Carcinoma.J Nucl Med2022
37520011Investigating of the role of CT scan for cancer patients during the first wave of COVID-19 pandemic.Res Diagn Interv Imaging2022
35740700Can <sup>18</sup>F-FDG PET/CT Radiomics Features Predict Clinical Outcomes in Patients with Locally Advanced Esophageal Squamous Cell Carcinoma?Cancers (Basel)2022
35543730Prostate cancer cardiac metastasis detected on serial imaging with [<sup>68</sup>Ga] PSMA-11 PET/CT.Eur J Nucl Med Mol Imaging2022
35664770Editorial: Breakthrough in Imaging-Guided Precision Medicine in Oncology.Front Oncol2022
35526957Pearls and Pitfalls of <sup>18</sup>FDG-PET Head and Neck Imaging.Neuroimaging Clin N Am2022
35626272Translating Molecules into Imaging-The Development of New PET Tracers for Patients with Melanoma.Diagnostics (Basel)2022
36551738Real-Time Split-Dose PET/CT-Guided Ablation Improves Colorectal Liver Metastasis Detection and Ablation Zone Margin Assessments without the Need for Repeated Contrast Injection.Cancers (Basel)2022
36180071Artificial intelligence and radiomics: fundamentals, applications, and challenges in immunotherapy.J Immunother Cancer2022
36357680Overall survival with circulating tumor DNA-guided therapy in advanced non-small-cell lung cancer.Nat Med2022
36054175Surgical Aspects of Primary Hyperparathyroidism.J Bone Miner Res2022
35041493Phase II Trial of Imatinib Plus Binimetinib in Patients With Treatment-Naive Advanced Gastrointestinal Stromal Tumor.J Clin Oncol2022
35247087Frequency and outcomes of MRI-detected axillary adenopathy following COVID-19 vaccination.Eur Radiol2022
32959115Clinical utility of perfusion (Q)-single-photon emission computed tomography (SPECT)/CT for diagnosing pulmonary embolus (PE) in COVID-19 patients with a moderate to high pre-test probability of PE.Eur J Nucl Med Mol Imaging2021
33602744Variations in the Course of the Carotid Arteries in Patients with Retropharyngeal Parathyroid Adenomas.AJNR Am J Neuroradiol2021
33625298Multidisciplinary Recommendations Regarding Post-Vaccine Adenopathy and Radiologic Imaging: <i>Radiology</i> Scientific Expert Panel.Radiology2021
33540118Preoperative imaging predicts change in bone mineral density after parathyroidectomy for primary hyperparathyroidism.Bone2021
33917470Preoperative Localization for Primary Hyperparathyroidism: A Clinical Review.Biomedicines2021
34463550Bronchial or Pulmonary Artery Chemoembolization for Unresectable and Unablatable Lung Metastases: A Phase I Clinical Trial.Radiology2021
34418873FDG PET/CT imaging features and clinical utility in COVID-19.Clin Imaging2021
34503082The Role of Cost-Effectiveness Analysis in Patient-Centered Cancer Care in the Era of Precision Medicine.Cancers (Basel)2021
34336643Updated Trends in Imaging Practices for Pancreatic Neuroendocrine Tumors (PNETs): A Systematic Review and Meta-Analysis to Pave the Way for Standardization in the New Era of Big Data and Artificial Intelligence.Front Oncol2021
34164727Assessing immune response upon systemic RNA vaccination on [18F]-FDG PET/CT for COVID-19 vaccine and then for immuno-oncology?Eur J Nucl Med Mol Imaging2021
32558723Ectopic Parathyroid Adenoma of the Piriform Sinus on Parathyroid 4D-CT and 99mTc-MIBI SPECT/CT.Clin Nucl Med2020
31783345Imaging-guided precision medicine in non-resectable gastro-entero-pancreatic neuroendocrine tumors: A step-by-step approach.Eur J Radiol2020
31961822Donor glucose-6-phosphate dehydrogenase deficiency decreases blood quality for transfusion.J Clin Invest2020
33438607A threshold-based method to predict thyroid nodules on scintigraphy scans.Biomed Phys Eng Express2020
32901568Role of Imaging in Esophageal Cancer Management in 2020: Update for Radiologists.AJR Am J Roentgenol2020
32816774A Simple Formula to Estimate Parathyroid Weight on 4D-CT, Predict Pathologic Weight, and Diagnose Parathyroid Adenoma in Patients with Primary Hyperparathyroidism.AJNR Am J Neuroradiol2020
32206839Prognostic 18F-FDG PET biomarkers in metastatic mucosal and cutaneous melanoma treated with immune checkpoint inhibitors targeting PD-1 and CTLA-4.Eur J Nucl Med Mol Imaging2020
32108700FLT-PET At 6 Weeks Predicts Response Assessed by CT at 12 Weeks in Melanoma Patients Treated With Pembrolizumab.Clin Nucl Med2020
32515679Identification of HER2-Positive Metastases in Patients with HER2-Negative Primary Breast Cancer by Using HER2-targeted <sup>89</sup>Zr-Pertuzumab PET/CT.Radiology2020
30371599Poorly Differentiated Primary Carcinoma of the Middle Ear on 18F-FDG PET/CT.Clin Nucl Med2019
31346755Prognostic and theranostic 18F-FDG PET biomarkers for anti-PD1 immunotherapy in metastatic melanoma: association with outcome and transcriptomics.Eur J Nucl Med Mol Imaging2019
31069132Increased bone marrow SUVmax on 18F-FDG PET is associated with higher pelvic treatment failure in patients with cervical cancer treated by chemoradiotherapy and brachytherapy.Oncoimmunology2019
30835187Diagnostic Performance of 4D CT and Sestamibi SPECT/CT in Localizing Parathyroid Adenomas in Primary Hyperparathyroidism.Radiology2019
30980115The role of multimodal imaging in guiding resectability and cytoreduction in pancreatic neuroendocrine tumors: focus on PET and MRI.Abdom Radiol (NY)2019
31002399Reexamination of the chromium-51-labeled posttransfusion red blood cell recovery method.Transfusion2019
31029010Tumor-induced osteomalacia - Current imaging modalities and a systematic approach for tumor localization.Clin Imaging2019
28646614Does breast MRI background parenchymal enhancement indicate metabolic activity? Qualitative and 3D quantitative computer imaging analysis.J Magn Reson Imaging2018
  • 1 - 50 of 58

Recommended Authors

Jeremie Calais
university of california los angeles
Career Start Year 2014
Number of shared co-authors 2
Tyler J Bradshaw
University of Wisconsin-Madison
Career Start Year 2013
Number of shared co-authors 1
Stephanie A Lee-Felker
David Geffen School of Medicine, University of California at Los Angeles
Career Start Year 2012
Number of shared co-authors 0
Samira M Sadowski
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 2012
Number of shared co-authors 0
Vincent Dunet
Lausanne University Hospital and University of Lausanne
Career Start Year 2011
Number of shared co-authors 0
Zhifang Wu
The First Hospital of Shanxi Medical University
Career Start Year 2009
Number of shared co-authors 0
Michael A Morris
Clinical Center, National Institutes of Health
Career Start Year 2009
Number of shared co-authors 1
Pedram Heidari
Massachusetts General Hospital
Career Start Year 2008
Number of shared co-authors 0
Spencer C Behr
University of California san francisco
Career Start Year 2007
Number of shared co-authors 0
Thomas A Hope
University of California san francisco
Career Start Year 2007
Number of shared co-authors 3
Babak Saboury
Clinical Center
Career Start Year 2006
Number of shared co-authors 1
Guido Davidzon
Stanford University
Career Start Year 2005
Number of shared co-authors 0
Youngho Seo
University of California san francisco
Career Start Year 2005
Number of shared co-authors 1
Nina Tunariu
The Institute of Cancer Research
Career Start Year 2005
Number of shared co-authors 4
Li-Ping Fu
Peking University
Career Start Year 2002
Number of shared co-authors 0
Zhaohui Zhu
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Career Start Year 2000
Number of shared co-authors 0
Steven S Raman
University of California, Los Angeles David Geffen School of Medicine
Career Start Year 1999
Number of shared co-authors 1
Chuong Bui
Nepean Hospital
Career Start Year 1999
Number of shared co-authors 0
Lance T Hall
University of Wisconsin Hospitals and Clinics
Career Start Year 1998
Number of shared co-authors 0
Nobuyuki Kosaka
University of Fukui.
Career Start Year 1997
Number of shared co-authors 0
Winnie Wing-Chuen Lam
Singapore General Hospital
Career Start Year 1997
Number of shared co-authors 0
Richard K G Do
Memorial Sloan Kettering Cancer Center
Career Start Year 1996
Number of shared co-authors 8
Baixuan Xu
First Medical Center, Chinese PLA General Hospital
Career Start Year 1994
Number of shared co-authors 0
Elizabeth C Jones
Clinical Center, National Institutes of Health
Career Start Year 1989
Number of shared co-authors 0
Johannes Czernin
university of california los angeles
Career Start Year 1987
Number of shared co-authors 1
Javier E Villanueva-Meyer
University of California san francisco
Career Start Year 1986
Number of shared co-authors 0
John J Sunderland
University of Iowa
Career Start Year 1986
Number of shared co-authors 2
Richard L Wahl
Mallinckrodt Institute of Radiology, Washington University in St. Louis
Career Start Year 1983
Number of shared co-authors 3
Peter L Choyke
National Cancer Institute, National Institutes of Health
Career Start Year 1982
Number of shared co-authors 1
Jiahe Tian
First Medical Center of Chinese PLA General Hospital
Career Start Year 1982
Number of shared co-authors 0

Collaborators

Chaitanya Divgi
Columbia University Medical Center Kreitchman PET Center
Co-authored papers 4
Francesca La Carpia
Columbia University Irving Medical Center
Co-authored papers 3
Mithat Gonen
Co-authored papers 3
Eldad A Hod
Columbia University Irving Medical Center, New York-Presbyterian Hospital
Co-authored papers 3
Mark Soffing
Columbia University Irving Medical Center
Co-authored papers 3
Joseph Schwartz
Icahn School of Medicine at Mount Sinai
Co-authored papers 3
Yelena Z Ginzburg
The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai
Co-authored papers 3
Heiko Sch??der
Memorial Sloan Kettering Cancer Center
Co-authored papers 3
Richard O Francis
Columbia University Irving Medical Center, New York-Presbyterian Hospital
Co-authored papers 3
Steven L Spitalnik
Columbia University Irving Medical Center, New York-Presbyterian Hospital
Co-authored papers 3
Beth H Shaz
Marcus Center for Cellular Cures, Duke University
Co-authored papers 3
Francesca Rapido
Gui de Chauliac Hospital, Montpellier University Medical Center
Co-authored papers 3
James C Zimring
University of Virginia
Co-authored papers 2
Angelo D'Alessandro
University of Colorado Anschutz Medical Campus
Co-authored papers 2
Andrew Eisenberger
NewYork-Presbyterian/Columbia University Irving Medical Center
Co-authored papers 2
Neeta Pandit-Taskar
Memorial Sloan Kettering Cancer Center
Co-authored papers 2
Nikolaus Schultz
Memorial Sloan Kettering Cancer Center
Co-authored papers 2
Stephen B Solomon
Memorial Sloan-Kettering Cancer Center
Co-authored papers 2
Michael F Berger
Co-authored papers 2
Caroline Robert
Co-authored papers 2
Tiffany Thomas
Columbia University Irving Medical Center, New York-Presbyterian Hospital
Co-authored papers 2
Debyani Chakravarty
Memorial Sloan Kettering Cancer Center
Co-authored papers 1
Ritika Kundra
Memorial Sloan Kettering Cancer Center
Co-authored papers 1
Ronglai Shen
Co-authored papers 1
Pamela H Nguyen
Columbia University Irving Medical Center
Co-authored papers 1
Sarah Gehrke
University of Colorado Anschutz Medical Campus
Co-authored papers 1
Vaios Hatzoglou
Memorial Sloan Kettering Cancer Center
Co-authored papers 1
Yu Chen
School of Pharmacy, University of Wisconsin-Madison
Co-authored papers 1
Julie A Reisz
University of Colorado Anschutz Medical Campus
Co-authored papers 1
Charles M Rudin
Memorial Sloan Kettering Cancer Center
Co-authored papers 1
Release 1.2